A Case of a Rapidly Progressive Small Bowel Lymphoma with High Ki-67 Expression

Jiyeon YOO; Hee-Jun KANG; Hyungkeun KIM; Sujeong HAN; Seung-Hyun OH; Sung-Hoon JUNG; Jung-Hwan OH; Eun-Jung JEON.
The Korean Journal of Helicobacter and Upper Gastrointestinal Research ; : 49-53, 2017.
Artículo en Ko | WPRIM | ID: wpr-7504

Documentos relacionados

  1. The evolving therapy of DLBCL: Bispecific antibodies.
  2. Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic Pitfalls.
  3. [The prospective on molecular diagnostics of primary mediastinal B-cell lymphoma and its clinical implications].
  4. Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era.
  5. Diffuse large B-cell lymphoma (DLBCL), 2 versus 3: end of a debate?
  6. Treatment intensification in diffuse large B-Cell lymphoma: lessons for clinical trial design.
  7. Arthritis and B-cell lymphoma: is the most obvious diagnosis the right one?
  8. Numerous B cells in a mediastinal mass, but not a B-cell lymphoma.
  9. Double-hit and triple-hit high-grade B-cell lymphoma of the ocular adnexa.
  10. Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy.